MLYS Mineralys Therapeutics, Inc.

HealthcareBiotechnology

$29.35

▼ 2.56%

37

QScore Signal

Short

Confidence: MEDIUM

Long-Term

30

Short-Term

43

Value

30

P/E-16.02

8

P/B3.81

46

P/S0.00

70

EV/EBITDA-10.96

5

Growth

39

Revenue Growth0.0%

28

EPS Growth37.4%

46

FCF Growth14.4%

46

Momentum

66

12-Month Return103.0%

100

3-Month Return4.0%

66

1-Month Return5.7%

64

RSI (14)44.60

50

50/200 MABearish

30

Profitability

19

ROE-27.9%

46

ROA-23.2%

0

Gross Margin0.0%

14

Operating Margin0.0%

21

Net Margin0.0%

26

FCF Yield-7.0%

0

Risk

25

Beta0.48

55

60-Day Volatility61.8%

0

Generated 5/7/2026, 9:21:14 PM · How is this calculated?

QScore Analysis